Analytical Data
-
Gene name
MYBPHL
- Application
-
Alternative Names
MBPHL_HUMAN; Mybphl; Myosin-binding protein H-like; OTTHUMP00000013793
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A2RUH7
-
Expression Region
1-354 aa
-
AA Sequence
MEAATAPEVA AGSKLKVKEA SPADAEPPQA SPGQGAGSPT PQLLPPIEEH PKIWLPRALR QTYIRKVGDT VNLLIPFQGK PKPQAIWTHD GCALDTRRVS VRNGEQDSIL FIREAQRADS GRYQLRVQLG GLEATATIDI LVIERPGPPQ SIKLVDVWGF SATLEWTPPQ DTGNTALLGY TVQKADTKSG LWFTVLEHYH RTSCIVSDLI IGNSYAFRVF AENQCGLSET APITTDLAHI QKAATVYKTK GFAQRDFSEA PKFTQPLADC TTVTGYNTQL FCCVRASPRP KIIWLKNKMD IQGNPKYRAL THLGICSLEI RKPGPFDGGI YTCKAVNPLG EASVDCRVDV KVPN
-
Molecular Weight
38.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYBPHL, or myb-like protein 2, is a member of the MYB transcription factor family, which is known for its role in regulating various biological processes, including cell differentiation, proliferation, and apoptosis. Research into MYBPHL has gained significance due to its involvement in key cellular pathways and its potential implications in developmental biology and cancer. Investigations have shown that MYBPHL is expressed in various tissues, suggesting it may play critical roles in tissue-specific functions and responses to environmental cues. Moreover, alterations in MYBPHL expression have been associated with several disease states, including malignancies, highlighting its potential as a biomarker or therapeutic target. Recombination techniques aimed at producing recombinant MYBPHL protein enable the detailed study of its structure, function, and interactions with other biomolecules. By elucidating the biochemical properties and signaling pathways involving MYBPHL, researchers aim to uncover its precise role in cellular mechanisms and its contributions to disease pathology. This research is crucial for developing targeted therapies and advancing our understanding of gene regulation in health and disease. Overall, the study of the MYBPHL recombinant protein is not only a step towards understanding the fundamental aspects of gene expression regulation but also towards translating this knowledge into clinical applications.
